Learning Objectives: -Summarize real-world data supporting the use of CAR T therapy beyond the pivotal trial inclusion criteria -Assess patients for outpatient CAR T therapy and long-term monitoring and management in partnership with specialized treatment centers -Describe the design and safety and efficacy data of clinical trials investigating the emerging uses of CAR T in multiple myeloma and non-Hodgkin lymphoma in increasingly earlier lines of therapy -Apply clinical trial data, real-world data, and expert opinion to rationally sequence approved CAR T therapies for multiple myeloma and non-Hodgkin lymphoma
- Provider:Medical Learning Institute, Inc.
- Activity Link: https://www.mycme.com/courses/expanding-car-t-cell-therapy-patient-populations-9816
- Start Date: 2024-11-20 06:00:00
- End Date: 2024-11-20 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Bristol Myers Squibb - Amount: 95429.0 - Is Kind Support: False Source: Janssen (Any division) - Amount: 62500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Internal Medicine, Medical Oncology
Subscribe
Login
0 Comments
Oldest